Living Well With Lymphoma
2 other identifiers
interventional
100
1 country
1
Brief Summary
In this study the investigators are proposing to evaluate the efficacy, sustainability, and mechanisms of 3 months of individualized counseling of the FRD delivered by registered dietitians, over 8 sessions by phone/video conferencing on fatigue, quality of life, and associated symptoms in persistently fatigued lymphoma cancer survivors compared to 3 months of individualized counseling of the attention control (matched for time and frequency of interactions with the FRD) the General Health Curriculum (GHC). The investigators will randomize and follow 68 lymphoma cancer survivors; accounting for a \~10% drop out rate to achieve a target of 60 patients that will complete the study. The investigators hypothesize that persistently fatigued lymphoma cancer survivors will experience improvements in fatigue, quality of life, and symptoms commonly associated with fatigue, which are then maintained at 15-months post-enrollment; and decreased CRP and alterations in inflammation-associated DNA methylation consistent with reduced inflammation from following the FRD as compared to the GHC.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable lymphoma
Started Mar 2024
Typical duration for not_applicable lymphoma
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 3, 2023
CompletedFirst Posted
Study publicly available on registry
September 21, 2023
CompletedStudy Start
First participant enrolled
March 7, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2028
October 30, 2025
October 1, 2025
3.5 years
April 3, 2023
October 28, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Brief Fatigue Inventory
To examine the effect of 3 months of FRD compared to an attention control GHC on persistent fatigue, measured with the Brief Fatigue Inventory. The instrument consists of 9 items, each measuring fatigue on a 0-10 scale, and is calculated from the mean of completed items
3 months after enrollment
Secondary Outcomes (8)
Examining the effect of 3 months of FRD compared to an attention control GHC on Quality of life
3 months after enrollment
The effect of 3 months of FRD compared to an attention control GHC on persistent sleep disturbance
3 months after enrollment
The effect of 3 months of FRD compared to an attention control GHC on persistent pain
3 months after enrollment
The effect of 3 months of FRD compared to an attention control GHC on persistent mood
3 months after enrollment
The effect of 3 months of FRD compared to an attention control GHC on persistent sexual function
3 months after enrollment
- +3 more secondary outcomes
Study Arms (2)
Fatigue Reduction Diet- FRD
EXPERIMENTAL3 months of individualized counseling of the FRD delivered by registered dietitians, over 8 sessions by phone/video conferencing on fatigue, quality of life, and associated symptoms in persistently fatigued lymphoma cancer survivors
General Health Curriculum- GHC
ACTIVE COMPARATOR3 months of individualized counseling of the attention control (matched for time and frequency of interactions with the FRD) the General Health Curriculum (GHC)
Interventions
Sessions will be \~15 minutes for 8 sessions. The FRD maintains participants on a diet with their typical caloric intake as assessed at baseline, and replaces some of their calories with the following foods on a daily basis: at least 50% of servings grains to be whole grains (these would replace non-whole grain foods); 5 servings of vegetables (1 leafy green, 1 tomato, and 1 yellow/orange); 2 servings of fruit (1 high in vitamin C), both fruit and vegetables would replace some of the carbohydrates from non-fruit and vegetable sources; 1 serving of fatty fish and or 1 serving of nuts and/or seeds (2 servings of nuts and/or seeds for vegetarians), both the fish, the nuts, and seeds will replace existing sources of fats and proteins in the diet.
These sessions will be matched counseling method, time spent (\~15 minutes per session), for 8 sessions. Registered Dietitians will discuss general health topics with the participant, excluding topics of diet and food.
Eligibility Criteria
You may qualify if:
- Women and men aged 18 years and older
- Diagnosis of lymphoma (Hodgkin and non-Hodgkin)
- Have an average persistent fatigue defined as ≥ 4 on the Brief Fatigue Inventory
- Fatigue must be attributed to lymphoma diagnosis
- Fatigue onset must be between 12months before diagnosis and any time after diagnosis
- Fatigue must not be attributed to other disease diagnoses
- Fruit and vegetable intake ≤5.5 servings/day
- Have, or be willing to create, an email address to receive study questionnaires electronically.
You may not qualify if:
- Medically unstable
- BMI\<18.5 kg/m2
- Have a current untreated diagnosis of mood disorder, e.g., bipolar or major depressive disorder
- Have a current untreated diagnosis of anemia
- Have a current untreated diagnosis of hypothyroidism
- Have an initiation, a cessation or change of treatment of any chronic medications, dietary supplements, behavioral therapy, physical therapy etc., or any planned change of medications, supplements, or therapies during the study
- Have a current diagnoses of cachexia
- Planning on becoming pregnant, currently pregnant or lactating
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Michigan
Ann Arbor, Michigan, 48109, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Suzie Zick
University of Michigan Rogel Cancer Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 3, 2023
First Posted
September 21, 2023
Study Start
March 7, 2024
Primary Completion (Estimated)
September 1, 2027
Study Completion (Estimated)
September 1, 2028
Last Updated
October 30, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share
No we would not make individual data just composite data available.